Scinovex
article Open AccessTop 1% cited

Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti–PD-1 Therapy

Clinical Cancer Research · 2014 · Vol. 20(19) · pp. 5064–5074

Abstract

Tumor PD-L1 expression reflects an immune-active microenvironment and, while associated other immunosuppressive molecules, including PD-1 and PD-L2, is the single factor most closely correlated with response to anti-PD-1 blockade. Clin Cancer Res; 20(19); 5064-74. ©2014 AACR.

Cancer Immunotherapy and BiomarkersImmune Cell Function and InteractionImmunotherapy and Immune ResponsesImmune systemTumor microenvironmentNivolumabMedicineMelanomaRenal cell carcinomaLung cancerCytotoxic T cellTumor-infiltrating lymphocytesImmunotherapy

MeSH terms

NivolumabAntibodies, MonoclonalAntineoplastic AgentsBiopsyHumansNeoplasm MetastasisNeoplasm StagingNeoplasmsGene ExpressionLymphocytes, Tumor-InfiltratingTreatment OutcomeMolecular Targeted TherapyTumor MicroenvironmentB7-H1 AntigenProgrammed Cell Death 1 Receptor

Funding

  • American Association for Cancer Research
  • Johns Hopkins University
  • Jounce Therapeutics
Citations
2,320
FWCI
121.84
field-weighted impact
References
45
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.